OAM
NVCR icon

Oppenheimer Asset Management’s NovoCure NVCR Stock Holding History

Oppenheimer Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,924
Closed -$288K – 1171
2022
Q4 		$288K Sell
3,924
-416
-10% -$31.3K ﹤0.01% 973
2022
Q3 		$330K Sell
4,340
-91
-2% -$7.1K 0.01% 933
2022
Q2 		$308K Sell
4,431
-181
-4% -$13.6K 0.01% 984
2022
Q1 		$382K Sell
4,612
-39
-0.8% -$2.87K 0.01% 973
2021
Q4 		$349K Sell
4,651
-212
-4% -$21.3K ﹤0.01% 1044
2021
Q3 		$565K Sell
4,863
-239
-5% -$36.1K 0.01% 903
2021
Q2 		$1.13M Sell
5,102
-137
-3% -$26.7K 0.02% 707
2021
Q1 		$692K Sell
5,239
-124
-2% -$19.6K 0.01% 833
2020
Q4 		$928K Sell
5,363
-361
-6% -$49.4K 0.02% 703
2020
Q3 		$637K Sell
5,724
-130
-2% -$10.4K 0.01% 749
2020
Q2 		$347K Buy
5,854
+63
+1% +$4.14K 0.01% 897
2020
Q1 		$390K Buy
5,791
+1,701
+42% +$134K 0.01% 805
2019
Q4 		$345K Buy
4,090
+1,596
+64% +$129K 0.01% 926
2019
Q3 		$187K Sell
2,494
-61
-2% -$4.88K ﹤0.01% 1051
2019
Q2 		$162K Sell
2,555
-434
-15% -$22K ﹤0.01% 1097
2019
Q1 		$144K Sell
2,989
-1,242
-29% -$59.8K ﹤0.01% 1122
2018
Q4 		$142K Buy
+4,231
New +$155K ﹤0.01% 1101

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

Oppenheimer Asset Management's NVCR Position: Q1 2023 in Review

Oppenheimer Asset Management sold out of NovoCure (NVCR) in Q1 2023, closing a stake of 3,924 shares — an estimated $288K sold.

Oppenheimer Asset Management first reported a position in NVCR in Q4 2018 and held it in 17 quarters. The position peaked at $1.13M in Q2 2021. 295 funds tracked by Wall St. Rank hold NVCR as of Q1 2023.

  • Oppenheimer Asset Management reported no remaining NovoCure position as of Q1 2023 after selling out during the quarter.
  • Oppenheimer Asset Management sold 3,924 NovoCure shares in Q1 2023, an estimated $288K.
  • Oppenheimer Asset Management first reported a position in NovoCure in Q4 2018 and held it in 17 quarters.
  • Oppenheimer Asset Management's NovoCure position peaked at $1.13M in Q2 2021.
  • 295 funds tracked by Wall St. Rank held NovoCure as of Q1 2023.

Based on Oppenheimer Asset Management's 13F filing for Q1 2023, filed 10 May 2023.